 NASHUA, N.H., March 09, 2022 GLOBE NEWSWIRE -- iCAD, Inc. NASDAQ: ICAD, a global medical technology leader providing innovative cancer detection and therapy solutions, today announced the Company will participate in the virtual 32nd Annual Oppenheimer Healthcare Conference, taking place March 15-17, 2022. 